Phase 1 Allergic Clinical Trials
5 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–5 of 5 trials
Recruiting
Phase 1Phase 2
Safety and Immunogenicity of Cat-allergen Intralymphatic Immunotherapy in Patients With Cat Allergy With and Without Asthma
Allergic AsthmaAllergic Rhinitis
University of Zurich36 enrolled1 locationNCT06960382
Not Yet Recruiting
Phase 1
A pilot study to evaluate the effectiveness of intranasal Botulinum Toxin Type A Spray for patients with Rhinitis
Allergic Rhinitis
Metro North Hospital and Health Service15 enrolled1 locationACTRN12624000772549
Completed
Phase 1
Effect of REVTx-99 on alleviating or preventing allergy symptoms
Allergic Rhinitis
Linear Clinical Research Ltd28 enrolled1 locationACTRN12621001455853
Completed
Phase 1
Phase I study to evaluate the safety and tolerability of single and multiple doses of intranasal pentosan polysulfate (Rhinosul 'Trademark') in healthy subjects
Hay feverAllergic Rhinitis
Paradigm Biopharmaceuticals18 enrolled1 locationACTRN12616000676415
Completed
Phase 1
A Phase Ib, Randomised, Placebo-Controlled, Double-Blind Study to Evaluate Potential Benefits of Two Concentrations of Betahistine Dihydrochloride Spray Administered as a Single Intranasal Dose in Adult Male and Female Volunteers with Eustachian Tube Dysfunction
Allergic rhinitis (hay fever)Eustachian tube dysfunctionRhinitis
Otifex Therapeutics24 enrolled1 locationACTRN12615000657527